抚顺社区2型糖尿病患者眼科检查与治疗现状
该研究为横断面调查,纳入抚顺市某社区2 006例资料完整的2型糖尿病患者,评估血糖、血压、血脂达标情况及眼科检查与糖尿病视网膜病变治疗现状。结果显示血糖、血压、血脂达标率分别为39.7%、31.0%、2.6%,确诊后仅27.1%接受过眼科检查,威胁视力糖尿病视网膜病变患者中82.2%未治疗。
要点
- 2型糖尿病患者糖化血红蛋白、血压、血脂达标率分别为39.7%、31.0%、2.6%
- 确诊糖尿病后仅27.1%接受过眼科检查,72.3%称内科医师未告知需查眼底
- 威胁视力糖尿病视网膜病变患者中82.2%未接受激光或玻璃体手术治疗
核心结论
- 抚顺城市社区2型糖尿病患者血糖、血压、血脂达标率低,眼科检查率低,威胁视力糖尿病视网膜病变治疗率低。
- 应加强内分泌医师与眼科合作,在社区层面开展糖尿病眼病防治宣教并建立糖尿病眼病筛查模式。
研究设计与样本
- 横断面调查研究,2012年7月至2013年5月在抚顺市将军街道开展。
- 共招募2型糖尿病患者2 224例,2 033例接受调查(受检率91.4%),资料完整用于分析者2 006例,其中男性819例、女性1 187例,年龄(62.0±9.0)岁。
- 采集基本信息、眼科检查、血液化验及问卷调查,率和构成比比较采用χ²检验或Fisher精确检验。
主要发现
- 糖化血红蛋白<7.0%者占39.7%(785例),血压<140/80 mmHg达标者占31.0%(568例),血脂4项均达标者占2.6%(40例)。
- 糖尿病确诊后进行过眼科检查者占27.1%(227例),72.3%(1 401例)称确诊时内科医师未告知需检查眼底。
- 确诊糖尿病视网膜病变856例,患病率44.3%;213例威胁视力糖尿病视网膜病变需眼科治疗,38例得到治疗,治疗率17.8%。
- 需要视网膜光凝治疗率14.6%(26例),玻璃体切除治疗率34.3%(12例)。
关键数值与推荐
- 血糖控制合格标准为糖化血红蛋白<7.0%,达标率39.7%。
- 血压控制合格标准为<140/80 mmHg(1 mmHg=0.133 kPa),达标率31.0%。
- 血脂4项指标均达标率2.6%。
- 威胁视力糖尿病视网膜病变需激光治疗或玻璃体手术,其中82.2%未治疗。
临床怎么用
- 社区2型糖尿病患者应常规评估血糖、血压、血脂达标情况并关注眼底筛查。
- 内科医师确诊糖尿病时应主动告知患者需进行眼底检查,并与眼科协作建立筛查模式。
- 对合并糖尿病视网膜病变者应识别威胁视力病变并及时转诊行激光或玻璃体手术治疗。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the attainment of therapeutic targets for glycosylated hemoglobin and blood pressure, ophthalmologic examination, diagnosis and treatment of diabetic retinopathy (DR) with type 2 diabetes mellitus. Methods: A cross-sectional study in type 2 diabetic patients was conducted in a community of Fushun between July 2012 and May 2013. Questionnaire, detailed ophthalmic examination and laboratory tests were completed to collect the information about sociodemographic and healthcare characteristics. Results: A total of 2 033 eligible patients with complete information were screened from 2 224 type 2 diabetic patients. Of them, the control rates of glycosylated hemoglobin(<7.0%), blood pressure[<140/80 mmHg (1 mmHg=0.133 kPa)] and serum lipid were 39.7%, 31.0% and 2.6%, respectively. Only 22.3% of the participants had ophthalmologic examination after the diagnosis of diabetes mellitus, and 72.2% of the participants in the study reported never receiving any recommendation for eye examinations from their physicians. The prevalence of DR was 44.3% in the study population, 27.1% receiving ophthalmologic examination ever. Among them, 213 patients had vision-threatening DR and required laser treatment or vitreous surgery, but 82.2% had not been treated. Conclusions: The investigation of the type 2 diabetic patients in a community of Fushun indicated that more than 60% of patients did not attain therapeutic targets for glycosylated hemoglobin, and 70% for blood pressure; 78% had not received ophthalmologic examination after the diagnosis of diabetes mellitus; 82% of vision-threatening DR patients had not been treated. Educational efforts should be aimed at improving knowledge of and compliance with these guidelines among both internists and eye care providers. (Chin J Ophthalmol, 2018, 54: 599-604). 目的: 调查社区2型糖尿病患者血糖血压血脂控制、眼科检查及患有糖尿病视网膜病变患者的眼科治疗情况。 方法: 横断面调查研究。2012年7月至2013年5月对抚顺市将军街道已确诊为2型糖尿病的居民进行基本信息采集、眼科检查、血液化验及问卷调查。率和构成比的比较采用χ(2)检验或Fisher精确检验。 结果: 共招募2型糖尿病患者2 224例,2 033例糖尿病患者接受调查,受检率为91.4%。资料完整用于本文分析者2 006例,其中男性819例,女性1 187例,年龄(62.0±9.0)岁。受检糖尿病患者中血糖控制合格率(糖化血红蛋白<7.0%)为39.7%(785例);血压控制合格率为31.0%(568例);血脂4项指标均达标2.6%(40例)。调查显示患者在糖尿病确诊后进行过眼科检查者占27.1%(227例),72.3%(1 401例)的患者称在确诊糖尿病时内科医师未告知需要检查眼底。本研究人群确诊糖尿病视网膜病变856例(患病率44.3%)。213例患有威胁视力的糖尿病视网膜病变需要眼科治疗,其中38例得到治疗,治疗率为17.8%,其中需要视网膜光凝治疗率14.6%(26例);玻璃体切除治疗率34.3%(12例)。 结论: 抚顺城市社区2型糖尿病患者中近60%血糖控制不达标;70%血压控制不达标;78%在确诊糖尿病后未进行过眼科检查;82%威胁视力的糖尿病视网膜病变患者未得到治疗。加强内分泌医师与眼科合作,在社区层面开展糖尿病患者眼病防治宣教及建立糖尿病眼病筛查模式应成为当前迫在眉睫的工作。(中华眼科杂志,2018,54:599-604).
引用
- Wen L, Sun X, Wang FH, et al. [The current situation of ophthalmologic examination and treatment of diabetic patients in a community of Fushun]. Zhonghua Yan Ke Za Zhi. 2018. PMID: 30107653. doi:10.3760/cma.j.issn.0412-4081.2018.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。